Deciphering Metabolic Adaptability of Leukemic Stem Cells
- PMID: 35756656
- PMCID: PMC9213881
- DOI: 10.3389/fonc.2022.846149
Deciphering Metabolic Adaptability of Leukemic Stem Cells
Abstract
Therapeutic targeting of leukemic stem cells is widely studied to control leukemia. An emerging approach gaining popularity is altering metabolism as a potential therapeutic opportunity. Studies have been carried out on hematopoietic and leukemic stem cells to identify vulnerable pathways without impacting the non-transformed, healthy counterparts. While many metabolic studies have been conducted using stem cells, most have been carried out in vitro or on a larger population of progenitor cells due to challenges imposed by the low frequency of stem cells found in vivo. This creates artifacts in the studies carried out, making it difficult to interpret and correlate the findings to stem cells directly. This review discusses the metabolic difference seen between hematopoietic stem cells and leukemic stem cells across different leukemic models. Moreover, we also shed light on the advancements of metabolic techniques and current limitations and areas for additional research of the field to study stem cell metabolism.
Keywords: hematopoietic stem cells; leukemia; leukemic stem cells (LSCs); metabolic techniques; metabolism.
Copyright © 2022 Patel, Nemkov, D’Alessandro and Welner.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
[Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].Rinsho Ketsueki. 2017;58(10):1838-1843. doi: 10.11406/rinketsu.58.1838. Rinsho Ketsueki. 2017. PMID: 28978822 Japanese.
-
Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.Cancer Drug Resist. 2022 May 5;5(2):344-367. doi: 10.20517/cdr.2021.140. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35800375 Free PMC article. Review.
-
[Recent progress in leukemic stem cell research for childhood leukemia].Rinsho Ketsueki. 2015 Oct;56(10):1871-81. doi: 10.11406/rinketsu.56.1871. Rinsho Ketsueki. 2015. PMID: 26458424 Japanese.
-
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?Cancers (Basel). 2017 Jun 30;9(7):74. doi: 10.3390/cancers9070074. Cancers (Basel). 2017. PMID: 28665351 Free PMC article. Review.
-
Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.Front Immunol. 2021 Oct 15;12:775128. doi: 10.3389/fimmu.2021.775128. eCollection 2021. Front Immunol. 2021. PMID: 34721441 Free PMC article. Review.
Cited by
-
Metabolic regulation of RNA methylation by the m6A-reader IGF2BP3.bioRxiv [Preprint]. 2024 Nov 3:2024.10.31.621399. doi: 10.1101/2024.10.31.621399. bioRxiv. 2024. PMID: 39554138 Free PMC article. Preprint.
-
Metabolism in hematology: Technological advances open new perspectives on disease biology and treatment.Hemasphere. 2025 May 19;9(5):e70134. doi: 10.1002/hem3.70134. eCollection 2025 May. Hemasphere. 2025. PMID: 40390870 Free PMC article. Review.
-
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia.Pharmaceuticals (Basel). 2024 Jul 5;17(7):894. doi: 10.3390/ph17070894. Pharmaceuticals (Basel). 2024. PMID: 39065744 Free PMC article.
-
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells.J Clin Med. 2025 Jan 10;14(2):392. doi: 10.3390/jcm14020392. J Clin Med. 2025. PMID: 39860398 Free PMC article.
-
Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis.Front Mol Biosci. 2023 Oct 31;10:1273046. doi: 10.3389/fmolb.2023.1273046. eCollection 2023. Front Mol Biosci. 2023. PMID: 38028538 Free PMC article. Review.
References
-
- Fendt SM, Frezza C, Erez A. Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy. Cancer Discov (2020) 10(12):1797–807. doi: 10.1158/2159-8290.CD-20-0844 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources